The development of electroencephalographic indices of anaesthetic depth has in turn generated interest in automated anaesthesia delivery systems using these as the input variable. In this paper, one patented closed loop anaesthesia delivery system (CLADS) (502/DEL/2003) is compared to manual control of propofol delivery titrated to the bispectral index (BIS™). Forty ASA I-II patients undergoing elective surgery under general anaesthesia were enrolled in the study. The study participants were randomised using computer generated random numbers to two equal groups. One group received propofol titrated by the CLADS while in the other group (control), anaesthetic delivery was manually titrated to BIS™. Closed loop anaesthetic delivery using our patented system led to lower induction doses of propofol (P<0.05) and less overshoot of the target BIS (P<0.05). The closed loop system maintained BIS to within ±10 of target for a significantly longer time during the maintenance phase of anaesthesia (P<0.01). Smaller amounts of anaesthetic agent were required (P <0.01) and there was faster postoperative recovery (P<0.05). Manual delivery of propofol required the infusion rate to be changed a median of 30 times , which required considerable time and attention by the anaesthetist. In conclusion, automated delivery of propofol adjusted to the bispectral index using our CLADS was both effective and efficient as compared to manual control.
The ideal variable with which to measure and titrate the depth of anaesthesia is not known. However, numerous indices have been developed to measure and titrate the delivery of anaesthetic agents to achieve a targeted depth of anaesthesia 1 . The bispectral index (BIS™, Aspect Medical Systems, Inc, Newton, MA, U.S.A.) is one such index 2 . Closed-loop control of drug administration uses an input variable (anaesthetic depth, blood pressure or the degree of neuromuscular blockade) to control the output (drug delivery rate) 3 . Because of more frequent sampling of the input variable and appropriate changes in the output, this method of drug delivery may outperform manual delivery of drugs in terms of the stability of the control variable 4 . Greater individualisation of pharmacokinetic and dynamic parameters may also result in using lesser amounts of drug to achieve a given therapeutic effect.
The closed-loop controlled administration of propofol has been used to provide sedation 5 as well as to anaesthetise patients during surgery 6 with reasonably good success. A new closed-loop anaesthesia delivery system (CLADS) has been designed and developed at the Postgraduate Institute of Medical Education and Research, Chandigarh, India. This system uses BIS as the control variable, a control system based on the clinical pharmacokineticinfusion pump as actuator.
The current study aimed to evaluate the CLADS in clinical practice by comparing its effectiveness in the economy of propofol consumption in achieving the designated target BIS™ and the possible effects of drug delivery on patient haemodynamics and recovery times by comparison of the system with manually set propofol infusions titrated to similar BIS™ values.
METHODS
Our closed-loop anaesthesia delivery system is a patented (502/DEL/2003) drug delivery system which can be used for induction and maintenance of total intravenous anaesthesia. Bispectral index *M.D, Ph.D., Professor.
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is the control variable with an averaging interval set at 15 seconds. A standard syringe infusion pump (Pilot-C, Fresenius, France) serves as the control actuator. An IBM compatible Pentium 4 (2 GHz) PC is used to implement the algorithm, to provide a user interface (RS-232) and to control communication with the A-2000 monitor and infusion pump. The system can be used for controlling propofol infusion to achieve a preset target BIS as set by the user both for induction as well as maintenance of anaesthesia. It can operate in two different modes. In manual mode, the user can control the system by adjusting delivery rate from the keyboard of the PC. In automatic mode, the system automatically controls the rate of propofol infusion. The user must enter a target BIS value and the risk status, i.e. high risk (e.g. ASA 4, NYHA III or above) or low risk (e.g. ASA physical status 1-3), of the patients. The risk status of patients determines the maximum allowable rate of drug infusion at induction as well as during maintenance of anaesthesia. In automatic mode, the system requests an update of the electrocalculates the BIS error (difference between the target and actual BIS value). This value is passed to the control algorithm, which uses the error to calculate an adjustment in rate of infusion needed to achieve target BIS. The decisions regarding the change in propofol rate are affected by the effect of previous decisions on the change in BIS taking into account the difference of current BIS from target BIS. It does not change propofol infusion rate at intervals less than 30 seconds (except for during induction phase) keeping in view the time interval for it to produce any effect on the BIS. If the changes in the BIS in shorter range of time intervals are not grossly different from the set target, the algorithm checks the trends of the BIS in long range of time intervals ( Figure 1 ). It uses proportional integral differential (PID) to make changes in the propofol rate based on its effect on the BIS in the previous decisions.
These decisions are based on an adaptive control algorithm developed and tested in a pilot study conducted at the institute of study.
After approval from the institutional ethics committee and written informed consent, 40 patients aged 18 to 65 years and ASA physical status 1-3 planned for undergoing elective noncardiac surgery (gall bladder, upper and lower GI surgery, hernia) under general anaesthesia were studied. Patients weighing <70% or >130% of their ideal body weight, those with a neurological disorder or those on psychotropic drugs (including alcohol) were excluded.
All patients received lorazepam 1-2 mg orally on the morning of surgery one to two hours prior to surgery. Non-invasive arterial blood pressure, heart rate and oxygen saturation measured on pulse oximetry were recorded every one minute during thereafter. All of these recorded patient variables, the BIS™ and the infusion rate of propofol were recorded online and stored for subsequent analysis. A BIS value of 50 was used as the set target point for induction and maintenance of anaesthesia. Patients received 2 μg/kg fentanyl three minutes prior to induction followed by 1 μg.kg -1 .h -1 continuous infusion for the duration of surgery.
Using computer generated random numbers, patients were assigned to receive anaesthesia using either the 'manual' or the 'automatic mode'. After induction, endotracheal intubation was facilitated with 0.1 mg/kg of vecuronium and patients were mechanically ventilated throughout the procedure. The time interval after attainment of target BIS at induction to cessation of closed-loop delivery at the end of surgery was taken as "closed-loop anaesthesia delivery" (CLAD) time.
The A-2000 monitor uses a signal quality index (SQI) algorithm to detect artifacts. The time duration for which the SQI was <15 and no BIS values were generated by the BIS monitor were subtracted from the total CLADS time to get the 'valid' CLAD time. The 'valid' CLAD time was used for performance analysis of the system. At the end of surgery both the closed-loop system as well as manual control were surgery, depending upon the duration of anaesthesia and recovery variables were noted.
The induction time (the time required to achieve target BIS after start of infusion), induction dose, minimum BIS within 30 seconds of induction and total dose of propofol, median duration of closedloop control or manual control, and median time interval between end of closed-loop control (or end of propofol infusion in manual control) and extubation were noted. All patients were subjected colleagues 7 and described by Nordstrom 8 for conscious awareness on discharge from the post anaesthesia care unit, the day after surgery and approximately a week thereafter. Anaesthetists involved in the study were well conversant with the use of Bispectral Index monitor as well as with the use of the CLADS.
Physiologic data are presented as mean (SD) and time intervals are presented as median (range). The performance of the system was assessed by calculating median performance error (MDPE), median absolute performance error (MDAPE), wobble and divergence (time related trends) using methods of Varvel et al 9 .
The performance error is given by the formula: MDPE and MDAPE are measures of bias and precision, respectively, wobble measures the intraindividual variability in the performance errors. The percent of time when BIS remained within ±10 of target BIS during closed-loop (CLADS group) or manual control (Control group) was also calculated. Adequacy of haemodynamic control was adjudged by the percentage of anaesthesia time the mean arterial blood pressure and heart rate (HR) was within ±25% of baseline.
Differences between the groups were analysed using the unpaired t-test for parametric data and the Mann-Whitney U test for non-parametric data. Count data were analysed using the chi-square test. Comparison of variances was done using the variance ratio test (F test). All analyses were performed using SPSS v11.0 for Windows (SPSS Inc., Chicago IL, U.S.A.) and a P From a pilot study, we estimated that manual control maintained BIS in the range of ±10 of the target 70% of the time. In order to assess the 20% improvement from this control, we calculated that we would need to recruit 36 patients to achieve 80% power at 5% Type I error. A total of 40 patients were recruited, taking into account possible inadvertent patient attrition.
RESULTS
Demographic characteristics of the two study groups were similar ( Table 1) haemodynamics adversely and the percentage fall in mean arterial blood pressure (lowest value obtained during induction compared to baseline) was not In the maintenance phase of anaesthesia, CLADS of propofol delivery (Table 3 ). Bispectral index was maintained within 10 units of the target value the closed-loop delivery system (87.32±9.1% as against 77.3±14.3%, P<0.01). While the median performance error between the groups was comparable, the MDAPE and wobble were disproportionately higher in the manual control group (P<0.01 and P<0.05 respectively). Though divergence was negative in both groups it was P<0.01) in manually controlled patients ( Table 3 ). Blood pressure as well as heart rate were maintained within 25% of baseline for comparable durations of time in both groups ( Table 3) . No patient in either group needed vasopressors, atropine or a vasodilator to maintain haemodynamic stability.
The total amount of propofol used in the CLADS group was 5.03±1.68 mg.kg -1 .h -1 which was group 7.33±2.07 mg.kg -1 .h -1 (P<0.01). Further, the quicker in the CLADS arm, 440 (250-620) seconds as against 535 (300-835) in the manual arm (P<0.05). Manual control of propofol delivery necessitated changes in the infusion rate a median of 30 times (IQR 12-45) by the anaesthetist. None of the patients in either groups reported awareness under anaesthesia.
DISCUSSION
The CLADS that we have developed outperformed manual delivery of propofol infusions titrated to the BIS™. The BIS™ was maintained within a narrow range of the designated target with minimal periods of excessive anaesthetic depth (e.g. as seen during induction) were less with CLADS.
Our BIS™ guided closed-loop system provided clinically adequate anaesthesia and satisfactory operating conditions in all studied patients during the period of automatic control which lasted between 53 and 302 minutes. The performance of the system as assessed by ability to control BIS closer to the target BIS appeared satisfactory. The CLADS Varvel et al 7 originally described the performance parameter for target control infusion system. These criteria have also been applied for studying the performance of closed-loop system after some 10 . MDPE is a signed value; it represents the direction (over-prediction or under-prediction) of performance error (PE) rather than size of errors, which is represented by MDAPE. The MDPE of 1 indicates that the system had a slight positive bias i.e. the median measured BIS were 1% greater than target BIS. An MDAPE value of 9.45% indicates that 50% of BIS values were within 9.45% of the set target BIS. Wobble measures the total intra individual variability in PE which was higher in the control group. Divergence measures the expected systemic time-related changes in performance. A positive value indicates progressive widening of the gap between target and measured value (divergence), whereas a negative value reveals that the measured values converge on the predicted values (convergence). The absolute value indicates the speed of convergence or divergence. A mean divergence of -0.0024 in CLADS group indicates that our system had slight tendency to decrease PE with time which was much less than that in manual ( Table 2) . It is expected when the anaesthetist tries to bring the BIS towards the both sides of the target as shown by higher MDAPE and wobble in the manual group (Table 2) .
It would have been reasonable to expect better haemodynamic control in the manual group as the anaesthetist is aware of haemodynamic variables while controlling the infusion rate. However, there was similar haemodynamic stability using CLADS. This may have been because CLADS used smaller anaesthetic dosages both at induction as well as during maintenance, with more frequent dose adjustments, hence avoiding periods of excessively deep anaesthesia. Moreover, the large number of times propofol infusion rates were changed manually translates to a substantial involvement of anaesthesia human resource in maintaining appropriate depth of anaesthesia. Use of a CLADS could enable the anaesthestist to devote attention to other aspects of anaesthesia management including haemodynamics.
Much of the work in this area has been possible because the BIS serves as a single integrated measure of anaesthetic depth 2 that can be the feedback variable of a closed-loop. Its other advantage has been its extensive validation as a depth of anaesthesia monitor 11 . Germane also to its use in other studies and ours has been the linear relationship between BIS and the hypnotic effect of propofol measured by propofol blood concentrations 12 .
Our results are generally comparable with previously reported descriptions of closed-loop drug delivery systems 6, 13 . There are various methods of automatic drug delivery 3 . A proportional integral derivative controller calculates the infusion rate using a mathematical formula based on the difference between measured effect value and chosen target and is blind to the effects of metabolism or hysteresis between administration and effect. Model-based adaptive control 14 , on the other hand, takes into account knowledge of drug effects, compares the predicted value of the control signal to the actual model parameters accordingly. In a simulation study, Struys et al 15 have shown that patient-individualised, model-based adaptive closed-loop with effect site control resulted in better control of controlled variable compared with standard PID controller with plasma site control. Our model of drug delivery is based on the latter concept and the inbuilt delay in decision before changing infusion rate takes into account the hysteresis between drug delivery and effect.
In contrast to many earlier studies 6 , our study included a control group. Struys et al 14 have similarly conducted a controlled trial of their system, however the control arm did not include BIS. Locher 16 et al have described a closed-loop inhalational anaesthesia system which was validated against a manual control arm-however the complicated anaesthesia delivery system described by them might hinder the widespread practice of a closed-loop inhalational delivery system. Liu 17 et al have since performed a randomised trial of closed-loop vs. manual control target controlled infusion (TCI)-effect site titration using BIS seemed to perform better than TCI. It seems therefore that a manual arm as control would systems and that the newest generation of closed-loop delivery systems would involve usage of some measure of end-organ effect as the feedback variable. Our study therefore successfully tests a new closed-loop delivery system against manual control, though the small numbers in the study, the lack of blinding inherent in the study design and the use in ASA I-II patients our study does validate the performance CLADS in our clinical practice and supports the use of appropriate closed-loop delivery systems in anaesthesia in general.
